1. 2020
  2. Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

    Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 Apr 2020, In : Cancers. 12, 4, 1017.

    Research output: Contribution to journalArticle

  3. Preclinical Targeted alpha- and beta(-)-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

    Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Windhorst, A. D., van der Aa, F., Lecocq, Q., Breckpot, K., Morgenstern, A., Bruchertseifer, F., Lahoutte, T., Devoogdt, N. & D'Huyvetter, M., Apr 2020, In : Cancers. 12, 4, 1017.

    Research output: Contribution to journalArticle

  4. 2019
  5. Theranostics in immuno-oncology using nanobody derivatives

    Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 25 Oct 2019, In : Theranostics. 9, 25, p. 7772-7791 20 p., 10.7150/thno.34941.

    Research output: Contribution to journalScientific review

  6. Theranostics in immuno-oncology using nanobody derivatives

    Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 14 Oct 2019, In : Theranostics. 9, 25, p. 7772-7791 20 p., thno.34941.

    Research output: Contribution to journalArticle

ID: 26529233